Successful Treatment of Human Monocytic Ehrlichiosis with Rifampin

Currently recommended treatment regimens for human monocytic ehrlichiosis (HME) include doxycycline or tetracycline. Antibiotic susceptibility studies demonstrate that rifampin has in vitro bactericidal activity against Ehrlichia. Case reports have suggested clinical response with rifampin treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Abusaada, Khalid, Ajmal, Saira, Hughes, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2016
Materias:
Infectious Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744069/
https://www.ncbi.nlm.nih.gov/pubmed/26918212
http://dx.doi.org/10.7759/cureus.444
Descripción
Sumario:Currently recommended treatment regimens for human monocytic ehrlichiosis (HME) include doxycycline or tetracycline. Antibiotic susceptibility studies demonstrate that rifampin has in vitro bactericidal activity against Ehrlichia. Case reports have suggested clinical response with rifampin treatment of human granulocytic anaplasmosis (HGA). We report the first case of HME successfully treated with rifampin.

Ejemplares similares